Presentation Proposal Form 2025 | International College of Surgeons, US Section

Please complete all fields in this form before submitting.
You are submitting a presentation proposal for the
2025 meetings of the ICSUS and AANOS in Charleston, SC
at the North Charleston Marriott Hotel being held from April 10-12.

Also use this form for AANOS submissions

DO NOT USE THIS FORM IF YOU ARE APPLYING TO THE RESEARCH SCHOLARSHIP COMPETITION.

Presentation Title
Please submit in Title format. DO NOT USE ALL CAPS
Example: Laparoscopic Management of Pancreatic Pseudocysts
Title should be short and concise. Note the character limit below.
Example title is 49 characters. *

Select primary specialty to which this presentation applies. *

If other Specialty indicate here...

Presenter Contact Information
Note that speaker substitutions will not be permitted.

FirstName *

LastName *

Degrees (MD, DO, PhD, etc.) *

Check here if you are an ICS member.

Check here if you are an AANOS member.

List your primary academic or professional affiliation.
Example: Professor of Surgery, University of Illinois, Chicago or
General Surgeon, Smallville Community Hospital

The information you submit will be used in documents prepared by ICSUS
as determined to be appropriate and consistent with our requirements. *

Enter your primary Medical Specialty *

Contact Information

Street Address *

City *

State *

Zipcode *

Enter the phone number where you prefer to be contacted. *

Type of Phone Number *

Enter your (the presenter) email address.
Please note that email will be the primary method of communication.
Provide an email address that you check regularly.
*

Enter email address for anyone who should be copied on communications
pertaining to your participation in our activity.

If submission is research based, enter the institution name(s) and location(s) where the research was conducted.

NOTE: If submission is accepted, preliminary Powerpoint presentations must be submitted by February 1, 2025. Draft PPT should be at least 75% complete, so that it can be reviewed for content validation. Final PPT must be submitted by March 12, 2025. If you have a financial relationship, these submission dates will be sooner.

Enter a description of your presentation in the fields below using the following guidelines.
(Use copy and paste to transfer information from MS Word or other program.)

Description should include information about ...

... the problem / surgical intervention the presentation covers.
... why the audience needs to know this information.
... what the learner will be able to accomplish after the presentation.
... how the audience will benefit from the presentation.

If presentation is research based, description should include 4 specific paragraphs that cover the Purpose, Methods, Results and Conclusions of the author.

Description should not exceed 500 words.

Tables, charts, graphs and pictures, should not be included and will not be published.

Using the guidelines above enter a description of your presentation in the fields below. Description can be submitted using only one field. Additional fields are provided for larger descriptions that may exceed field limitations. *

Other description information here...

Additional description here...

And here...

Needs Assessment Data

In the space below, please indicate how the need for this presentation was brought to your attention.
(Possible ways are: review of journal article, medical audit, advice from or discussion with experts, new technology, discussion with colleagues during staff meetings, survey results, personal experience, etc.)

List sources here.

FINANCIAL DISCLOSURES

The Importance of Identification. In order for the audience to evaluate information, analysis and opinions presented during a CME activity sponsored by the International College of Surgeons-United States Section (ICSUS), it is crucial that the audience be informed of ALL financial relationships of a planner, speaker, author, peer-reviewer or spouse. All planners, speakers, authors and peer-reviewers for a CME activity are required to submit FULL DISCLOSURE of ALL financial relationships with ineligible companies prior to the CME activity including those of a spouse or domestic partner. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

A conflict of interest (COI) occurs when there is a divergence between an individual's private interests and his or her professional obligations to ICSUS such that an independent observer might reasonably question whether the individual's professional actions or decisions are determined by considerations of personal gain, financial or otherwise. A conflict of interest depends on the situation, and not on the character or actions of the individual.

A COI is present when a planner, speaker, author, peer-reviewer or spouse has both a current financial relationship with an ineligible company and the opportunity to affect content relevant to products or services of that ineligible company. Conflicts of interest are identified through an analysis of the information disclosed and an understanding of the planned content of the CME activity.

In order for the ICSUS to determine whether a conflict of interest exists, you must provide information about all financial relationships you have with any and all ineligible companies within the past 24 months. This includes relationships with companies that may not have an interest in your presentation, but with which you have a relationship. ICSUS must be informed of all relationships to independently make the determination as to whether or not the relationship is relevant to your presentation. Note that you should also indicate if the relationship has ended and when.

I have read the ICSUS policies regarding “financial disclosure” (click here to view complete policy and FAQs) and I attest that:

To the best of my knowledge: *

I DO NOT have any financial relationships to report.

I DO have the following relationships to report...

Clear Selection

List Financial Relationship(s)
Include relationship (paid speaker, consultant, shareholder, etc.) and name of company.
Example: Consultant - Ethicon - Ongoing (or)
Speaker - Pfizer - Ended July 2023

Speakers are also required to report if their presentation includes discussion(s) of investigational products or products not labeled for use.

Off-Label Disclosure: (Including Generic Trade Names and Reporting Scientific Research) Presentations must give a balanced view of options. Use of generic names in your presentation will contribute to this impartiality. Presentations supported by a commercial entity reporting the results of scientific research must conform to the generally accepted standards of experimental design, data collection and analysis. When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is discussed during an educational activity it is required that the speaker disclose that the product is not labeled for the use under discussion or that the product is still investigational.

This Presentation: *

DOES NOT include information about product(s) not labeled for use or investigational

DOES include information about procedure(s)/product(s) not labeled for use and/or are investigational.
I understand that I must disclose this information to the audience prior to the presentation.

Clear Selection

Off-Label Procedure(s)/Product(s) under investigation include:

Click here to review Speaker Guidelines

By clicking the following button and submitting the information above, you acknowledge that you are digitally signing this document and are legally bound as if you submitted this information in print form.

In addition, by submitting this form you agree that you have reviewed the Speaker Guidelines and will comply with the terms and conditions contained therein. This agreement includes, but is not limited to, meeting submission deadlines for additional information that will be requested. Failure to comply with deadlines or respond to requests will result in removal from the program.
*

I agree to comply with the Speaker Guidelines and other requirements, including payment of appropriate meeting registration fees prior to the deadline identified by ICSUS staff. I also acknowledge that I am aware presentations submitted for consideration are typically provided with 10-15 minutes during the program and I will ensure that my oral presentation does not exceed this time limit. (The exact time allotted will be confirmed prior to the meeting.)

Clear Selection

Enter your name *

Date *

Your form submission WILL be encrypted using SSL to ensure your privacy.